Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.
Kass R, Agha J, Bellone S, Palmieri M, Canè S, Bignotti E, Henry-Tillman R, Hutchins L, Cannon MJ, Klimberg S, Santin AD. Kass R, et al. Among authors: bignotti e. J Surg Res. 2003 Jun 15;112(2):189-97. doi: 10.1016/s0022-4804(03)00147-1. J Surg Res. 2003. PMID: 12888337 Free article.
Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R, Bellone S, Palmieri M, Canè S, Bignotti E, Henry-Tillman R, Hutchins L, Cannon MJ, Klimberg S, Santin AD. Kass R, et al. Among authors: bignotti e. Breast Cancer Res Treat. 2003 Aug;80(3):275-85. doi: 10.1023/A:1024938215782. Breast Cancer Res Treat. 2003. PMID: 14503800
Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
Santin AD, Bellone S, Palmieri M, Bossini B, Cane' S, Bignotti E, Roman JJ, Cannon MJ, Pecorelli S. Santin AD, et al. Among authors: bignotti e. Int J Gynecol Cancer. 2004 Jan-Feb;14(1):64-75. doi: 10.1111/j.1048-891x.2004.014175.x. Int J Gynecol Cancer. 2004. PMID: 14764031 Free article.
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Among authors: bignotti e. Int J Cancer. 2004 Oct 20;112(1):14-25. doi: 10.1002/ijc.20408. Int J Cancer. 2004. PMID: 15305371 Free article.
Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
Santin AD, Zhan F, Bignotti E, Siegel ER, Cané S, Bellone S, Palmieri M, Anfossi S, Thomas M, Burnett A, Kay HH, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Among authors: bignotti e. Virology. 2005 Jan 20;331(2):269-91. doi: 10.1016/j.virol.2004.09.045. Virology. 2005. PMID: 15629771 Free article.
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD. Bignotti E, et al. Gynecol Oncol. 2006 Nov;103(2):405-16. doi: 10.1016/j.ygyno.2006.03.056. Epub 2006 May 24. Gynecol Oncol. 2006. PMID: 16725184
83 results